Breast Cancer Chemo Charlotte NC

Among women with locally advanced breast cancer who undergo the same class of chemotherapy, race doesn't affect the odds of having no sign of disease at surgery, a new study finds. Having no sign of the disease is considered a good sign that bodes well for a woman's prognosis, although it's not a guarantee that the cancer has vanished for good, the study authors noted.

Vincent Voci
(704) 333-8300
2620 East 7th Street
Charlotte, NC
Specialties
Cosmetic Surgery
Insurance
Medicare Accepted: No
Workmens Comp Accepted: No
Accepts Uninsured Patients: No
Emergency Care: No


Data Provided by:
Hope Peek, L.Ac., MSOM, Dipl. OM (NCCAOM)
(704) 595-9878
700 East Boulevard
Charlotte, NC
Business
Charlotte Acupuncture and Wellness Center, In
Specialties
Acupuncture, Chinese Herbal Medicine Tui Na Acupressure Nutritional Therapy Thermal Therapies
Doctor Information
Residency Training: Master of Science in Oriental Medicine
Medical School: Southwest Acupuncture College - Santa Fe, NM,
Additional Information
Member Organizations: AAOM NCAAOM


Data Provided by:
Galen Grayson, MD
(704) 295-0001
817 E Morehead St
Charlotte, NC
Business
Genesis Eye Center
Specialties
Ophthalmology

Data Provided by:
ChiroMed Plus
(704) 341-5200
6401 Carmel Rd.
Charlotte, NC

Data Provided by:
Pai Clinic of Chiropractic & Sports Medicine
(704) 599-0900
8821 University East Dr #100
Charlotte, NC

Data Provided by:
Thomas A Roberts Jr., MD
(704) 377-4009
2015 Randolph Rd
Charlotte, NC
Business
Charlotte Gastroenterology & Hepatology PLLC
Specialties
Gastroenterology

Data Provided by:
Todd Trembula, L.Ac., MSOM, Dipl. OM (NCCAOM)
(704) 595-9878
700 East Boulevard
Charlotte, NC
Business
Charlotte Acupuncture and Wellness Center, In
Specialties
Acupuncture, Chinese Herbal Medicine Tui Na Acupressure Nutritional Therapy Thermal Therapies
Doctor Information
Residency Training: Master of Science in Oriental Medicine
Medical School: Southwest Acupuncture College - Santa Fe, NM,
Additional Information
Member Organizations: AAOM NCAAOM


Data Provided by:
Michael Norman
(704) 446-1422
1000 Blythe Blvd
Charlotte, NC
Specialties
Pediatrics

Data Provided by:
Carolinas Veterinary Medical Hospital
(704) 752-7227
10330 Feld Farm Lane
Charlotte, NC

Data Provided by:
Chiropractic Fitness
(704) 817-4272
8316 Pineville Matthews Rd
Charlotte, NC

Data Provided by:
Data Provided by:

Breast Cancer Chemo

Provided By:

WEDNESDAY, Oct. 14 (HealthDay News) -- Among women with locally advanced breast cancer who undergo the same class of chemotherapy, race doesn't affect the odds of having no sign of disease at surgery, a new study finds.

Having no sign of the disease is considered a good sign that bodes well for a woman's prognosis, although it's not a guarantee that the cancer has vanished for good, the study authors noted.

"Our findings confirm [that having no sign of the disease] is a strong prognostic indicator and a surrogate for good survival, despite a patient's race, and that it's vital we continue to strive towards achieving this milestone for all women with breast cancer," said study co-author Dr. Mariana Chavez-MacGregor, a medical oncology fellow at the University of Texas M.D. Anderson Cancer Center. "The study also mandates that we continue to research the differences across races in breast cancer."

Researchers know that there are racial disparities when it comes to breast cancer. While black women are less likely to develop breast cancer than white women, their death rate is 37 percent higher. The death rate is also increased in Hispanic women, studies have found.

It is unclear why the disparities exist, and researchers continue to try to determine whether it has something to do with access to health care and screening or variations in the tumors between women of different races.

The new study by Chavez-MacGregor and colleagues at the University of Texas M.D. Anderson Cancer included 2,074 patients diagnosed and treated for stage II and III breast cancer. The average age of the women was 50, and they all received neoadjuvant anthracycline- and taxane-based chemotherapy.

According to the researchers, who were to report their findings at the 2009 Breast Cancer Symposium held Oct. 8 to 10 in San Francisco, there was no statistical difference in the percentages of patients who reached what is known as "pathological complete response." The rate was 12.3 percent in white patients, 12.5 percent in black patients, 14.2 percent in Hispanic patients and 11.5 percent in patients of other races.

Overall survival rates for five years were 79 percent in whites, 57 percent in blacks, 79 percent in Hispanics and 84 percent in other races, the study authors noted.

More information

Learn more about breast cancer from the U.S. National Cancer Institute.

SOURCE: University of Texas M.D. Anderson Cancer Center, news release, Oct. 14, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com